vigilance and Benefit-Risk Management Executive Directorate is concerned with detection, assessment and prevention of adverse drug reaction "ADR".
Objectives of the center
1- Early detection of adverse drug reactions.
2- Detection of increase in frequency of (known) adverse reaction.
3- Identification of risk factors and possible mechanisms underlying adverse reactions.
4- Estimation of quantitative aspects of benefit/risk analysis and dissemination of information needed to improve drug prescribing and regulation.
5- Prevention of adverse drug reactions.
6- Drug quality surveillance.
7- Encouraging rational and safe use of drugs.
8- Communication with international institutions working in pharmacovigilance.